Prostate cancer is the second most common cancer in men, and almost 300,000 individuals are diagnosed with it each year in the U.S. To develop a consistent method of estimating prostate cancer size, ...

Expert answers to patients’ questions were offered as part of the CURE® Educated Patient® Prostate Cancer Summit.

Ideally, prostate MRI should not be performed for at least ... and overlap of diffusion values between benign and malignant lesions. [67] There is no ADC threshold value that will reliably ...

Researchers determine whether artificial intelligence-based MRI data could predict prostate cancer patient outcomes.

Researchers trained and validated an AI model based on MRI scans from more than 700 prostate cancer patients. The model was ...

Abnormal results on a prostate-specific antigen (PSA ... but none got a systematic biopsy. Men with suspicious lesions on MRI got a targeted biopsy. This initial screening round was followed by repeat ...

Prostate cancer remains a significant health concern for men, particularly those aged between 50 and 60 years.

Adapt biopsy sampling in order to accurately detect prostate high grade targets identified by the image modality (MRI, PET…). Use KOELIS precise Elastic Tracking to Frame the lesions before ...

Researchers at Mass General Brigham have developed and tested an AI model of reliably assess the size of prostate tumours.

The model was able to identify and demarcate the edges of 85% of the most radiologically aggressive prostate lesions ... in the journal Radiology. MRI has improved the ability for clinicians ...